Company Description

BioInnovatise is a growing, minority-owned biotechnology company that serves research and development laboratories in the I-270 Technology Corridor, BioCapital, and beyond. Their teams advise and produce custom projects that further the research of numerous startups, large pharmaceutical companies, academic labs, and government agencies, including the NIH and FDA. They specialize in molecular biology products and services to advance research in the early discovery phases of cell and gene therapy, immunotherapy, oncology, precision medicine, regenerative medicine, stem cell research, and vaccine development.